trial_id stringlengths 11 11 | question stringlengths 154 5.24k | options dict | answer stringclasses 4
values | trials listlengths 4 4 | id int64 0 27.3k | split stringclasses 2
values |
|---|---|---|---|---|---|---|
NCT00004554 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Sertraline for Alcohol Dependence and Depression
Brief Summary: This study will examine depressed alcoholic outpatients to assess whether combining naltrexone (Revia) and sertraline (Zoloft) will result in greater reducti... | {
"A": "Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Other: active venlafaxine and active rTMS-repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed | Arm Label: B; Type: EXPERIMENTAL; Interventions: Other: active rTMS -repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed and... | D | [
"NCT00714090",
"NCT00021528",
"NCT00693849",
"NCT00004554"
] | 200 | train |
NCT00004562 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Occluded Artery Trial (OAT) - Randomized Comparative Effectiveness Trial of PCI and Medical Therapy Only Post MI
Brief Summary: The purpose of this study is to determine whether opening an occluded infarcted artery 3-28 d... | {
"A": "Intervention Type: DRUG; Name: clopidogrel (SR25990C); Assigned to Arm(s): N/A",
"B": "Arm Label: Optimal Medical Therapy Only (MED); Type: ACTIVE_COMPARATOR; Interventions: Drug: Beta adrenergic blockers, Drug: Platelet inhibitors, Drug: ACE Inhibitors | Arm Label: Percutaneous Coronary Intervention (PCI);... | B | [
"NCT00243178",
"NCT00004562",
"NCT00600483",
"NCT00139815"
] | 201 | train |
NCT00004563 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cyclophosphamide Versus Placebo in Scleroderma Lung Study
Brief Summary: To evaluate the efficacy and safety of cyclophosphamide versus placebo for the prevention and progression of symptomatic pulmonary disease in patien... | {
"A": "Arm Label: Mycophenolate Arm; Type: EXPERIMENTAL; Interventions: Drug: Mycophenolate mofetil | Arm Label: Cyclophosphamide Arm; Type: EXPERIMENTAL; Interventions: Drug: Cyclophosphamide, Drug: Placebo | Intervention Type: DRUG; Name: Mycophenolate mofetil; Assigned to Arm(s): Mycophenolate Arm | Intervention ... | D | [
"NCT00883129",
"NCT00114530",
"NCT00278525",
"NCT00004563"
] | 202 | train |
NCT00004563 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cyclophosphamide Versus Placebo in Scleroderma Lung Study
Brief Summary: To evaluate the efficacy and safety of cyclophosphamide versus placebo for the prevention and progression of symptomatic pulmonary disease in patien... | {
"A": "Arm Label: Cylophosphamide; Type: EXPERIMENTAL; Interventions: Drug: Cyclophosphamide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Cyclophosphamide; Assigned to Arm(s): Cylophosphamide | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s)... | A | [
"NCT00004563",
"NCT01366209",
"NCT00287729",
"NCT00287716"
] | 203 | train |
NCT00004732 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Brief Summary: The purpose of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) is to compare the relatively new procedure of... | {
"A": "N/A",
"B": "Arm Label: Carotid Artery Endarterectomy (CEA); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Carotid Endarterectomy (CEA) | Arm Label: Carotid Artery Stenting (CAS); Type: ACTIVE_COMPARATOR; Interventions: Device: Carotid Artery Stenting (CAS) | Intervention Type: PROCEDURE; Name: Carotid ... | B | [
"NCT02536378",
"NCT00004732",
"NCT00231270",
"NCT01685567"
] | 204 | train |
NCT00004732 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Brief Summary: The purpose of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) is to compare the relatively new procedure of... | {
"A": "Arm Label: Carotid Artery Endarterectomy (CEA); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Carotid Endarterectomy (CEA) | Arm Label: Carotid Artery Stenting (CAS); Type: ACTIVE_COMPARATOR; Interventions: Device: Carotid Artery Stenting (CAS) | Intervention Type: PROCEDURE; Name: Carotid Endarterectomy... | A | [
"NCT00004732",
"NCT01763320",
"NCT01968122",
"NCT02034058"
] | 205 | train |
NCT00004732 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Brief Summary: The purpose of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) is to compare the relatively new procedure of... | {
"A": "Arm Label: Intracranial stenting group; Type: EXPERIMENTAL; Interventions: Procedure: Intracranial stenting group | Arm Label: medical group; Type: ACTIVE_COMPARATOR; Interventions: Drug: medical group | Intervention Type: PROCEDURE; Name: Intracranial stenting group; Assigned to Arm(s): Intracranial stenting... | C | [
"NCT01763320",
"NCT00576693",
"NCT00004732",
"NCT00059306"
] | 206 | train |
NCT00004732 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Brief Summary: The purpose of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) is to compare the relatively new procedure of... | {
"A": "Arm Label: Carotid Artery Endarterectomy (CEA); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Carotid Endarterectomy (CEA) | Arm Label: Carotid Artery Stenting (CAS); Type: ACTIVE_COMPARATOR; Interventions: Device: Carotid Artery Stenting (CAS) | Intervention Type: PROCEDURE; Name: Carotid Endarterectomy... | A | [
"NCT00004732",
"NCT02089217",
"NCT00830232",
"NCT00106938"
] | 207 | train |
NCT00004857 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase II Study of Fludarabine Induction Followed by CAMPATH-1H Consolidation in Untreated Patients With B-Cell Chronic Lymphocytic Leukemia
Brief Summary: RATIONALE: Drugs used in chemotherapy use different ways to stop... | {
"A": "Arm Label: Arm A (CLL/SLL subjects); Type: EXPERIMENTAL; Interventions: Drug: ABT-199 | Arm Label: Arm B (NHL subjects); Type: EXPERIMENTAL; Interventions: Drug: ABT-199 | Intervention Type: DRUG; Name: ABT-199; Assigned to Arm(s): Arm A (CLL/SLL subjects), Arm B (NHL subjects)",
"B": "Arm Label: Fludarabin... | B | [
"NCT01328626",
"NCT00004857",
"NCT00093314",
"NCT01744691"
] | 208 | train |
NCT00004978 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Open-Label, Phase III, International Study of Subcutaneous Recombinant IL-2 in Patients With HIV-1 Infection and CD4+ Cell Counts 300/mm^3 or Greater: Evaluation of Subcutaneous Proleukin in a Randomized Int... | {
"A": "Arm Label: rIL-2; Type: EXPERIMENTAL; Interventions: Drug: Recombinant interleukin-2 (rIL-2) | Arm Label: No rIL-2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Recombinant interleukin-2 (rIL-2); Assigned to Arm(s): rIL-2",
"B": "Arm Label: No IL-2; Type: NO_INTERVENTION; Inter... | A | [
"NCT00004978",
"NCT00110812",
"NCT00000923",
"NCT00013611"
] | 209 | train |
NCT00004992 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The Diabetes Prevention Program is a nationwide clinical study to answer the question: Can Type 2 diabetes (also called noninsulin-dependent or adult-onset diabetes) be prevented or delayed? The study h... | {
"A": "Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: TV viewing reduction | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: No TV viewing reduction | Intervention Type: BEHAVIORAL; Name: No TV viewing reduction; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name:... | B | [
"NCT00622050",
"NCT00004992",
"NCT02609438",
"NCT01688804"
] | 210 | train |
NCT00004992 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The Diabetes Prevention Program is a nationwide clinical study to answer the question: Can Type 2 diabetes (also called noninsulin-dependent or adult-onset diabetes) be prevented or delayed? The study h... | {
"A": "Intervention Type: BEHAVIORAL; Name: obesity intervention; Assigned to Arm(s): N/A",
"B": "Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metformin | Arm Label: Intensive Lifestyle; Type: ACTIVE_COMPARATOR; Int... | B | [
"NCT00435734",
"NCT00004992",
"NCT00289237",
"NCT00038727"
] | 211 | train |
NCT00004992 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The Diabetes Prevention Program is a nationwide clinical study to answer the question: Can Type 2 diabetes (also called noninsulin-dependent or adult-onset diabetes) be prevented or delayed? The study h... | {
"A": "Arm Label: Short Message Service (SMS); Type: EXPERIMENTAL; Interventions: Behavioral: Short Message Service (SMS) | Arm Label: Standard usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Short Message Service (SMS); Assigned to Arm(s): Short Message Service (SMS)",
... | C | [
"NCT01556880",
"NCT00518167",
"NCT00004992",
"NCT00409422"
] | 212 | train |
NCT00004992 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The Diabetes Prevention Program is a nationwide clinical study to answer the question: Can Type 2 diabetes (also called noninsulin-dependent or adult-onset diabetes) be prevented or delayed? The study h... | {
"A": "Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Empagliflozin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Empagliflozin | Intervention Type: DRUG; Name: Empagliflozin; Assigned to Arm(s): Empagliflozin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Pla... | B | [
"NCT02998970",
"NCT00004992",
"NCT03036150",
"NCT01144338"
] | 213 | train |
NCT00005014 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Placebo-Controlled Study of Risperidone for the Treatment of Children and Adolescents With Autism and Negative Behavioral Symptoms
Brief Summary: This study is designed to determine the effectiveness of risperidone, a dru... | {
"A": "Arm Label: Memantine 1; Type: EXPERIMENTAL; Interventions: Drug: Memantine Hydrochloride (HCl) | Arm Label: Memantine 2; Type: EXPERIMENTAL; Interventions: Drug: Memantine Hydrochloride (HCl) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo capsules | Intervention Type: DRUG; Name:... | D | [
"NCT01592747",
"NCT00468130",
"NCT01372449",
"NCT00005014"
] | 214 | train |
NCT00005014 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Placebo-Controlled Study of Risperidone for the Treatment of Children and Adolescents With Autism and Negative Behavioral Symptoms
Brief Summary: This study is designed to determine the effectiveness of risperidone, a dru... | {
"A": "Arm Label: Fluoxetine; Type: EXPERIMENTAL; Interventions: Drug: Fluoxetine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): Fluoxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo",
"B": "In... | B | [
"NCT00515320",
"NCT00005014",
"NCT00065962",
"NCT00380692"
] | 215 | train |
NCT00005014 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Placebo-Controlled Study of Risperidone for the Treatment of Children and Adolescents With Autism and Negative Behavioral Symptoms
Brief Summary: This study is designed to determine the effectiveness of risperidone, a dru... | {
"A": "Arm Label: MPH Trial-Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: MPH Trial: Low Dose; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methylphenidate-extended release, Drug: Methylphenidate-immediate release | Arm Label: MPH Trial: Med Dose; Type: ACTIVE_COMPARATOR; Interventio... | D | [
"NCT00178503",
"NCT00004486",
"NCT00576732",
"NCT00005014"
] | 216 | train |
NCT00005052 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Adjuvant Ganglioside GM2-KLH/QS-21 Vaccination: Post-Operative Adjuvant Ganglioside GM2-KLH/QS-21 (BMS-248479) Vaccination Treatment After Resection of Primary Cutaneous Melanoma Thicker Than 1.5mm (AJCC/UICC Stage II, T3... | {
"A": "Arm Label: Arm A: 2 courses ipi 3 + nivo 1; Type: EXPERIMENTAL; Interventions: Drug: Ipilimumab, Drug: Nivolumab, Procedure: Surgery, Procedure: Blood for PBMCs, Procedure: Biopsies | Arm Label: Arm B: 2 courses ipi 1 + nivo 3; Type: EXPERIMENTAL; Interventions: Drug: Ipilimumab, Drug: Nivolumab, Procedure: S... | B | [
"NCT02977052",
"NCT00005052",
"NCT01134614",
"NCT01227889"
] | 217 | train |
NCT00005052 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Adjuvant Ganglioside GM2-KLH/QS-21 Vaccination: Post-Operative Adjuvant Ganglioside GM2-KLH/QS-21 (BMS-248479) Vaccination Treatment After Resection of Primary Cutaneous Melanoma Thicker Than 1.5mm (AJCC/UICC Stage II, T3... | {
"A": "Intervention Type: BIOLOGICAL; Name: GM2-KLH vaccine; Assigned to Arm(s): N/A | Intervention Type: BIOLOGICAL; Name: QS21; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: adjuvant therapy; Assigned to Arm(s): N/A",
"B": "Arm Label: Ipilimumab 10 mg/kg + HDI; Type: EXPERIMENTAL; Interventions: ... | A | [
"NCT00005052",
"NCT01608594",
"NCT01989572",
"NCT00623766"
] | 218 | train |
NCT00005094 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention of Sporadic Colorectal Adenomas With Celecoxib
Brief Summary: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. The use of celecoxib has been approved for use in r... | {
"A": "Arm Label: A; Type: PLACEBO_COMPARATOR; Interventions: Drug: Celecoxib | Intervention Type: DRUG; Name: Celecoxib; Assigned to Arm(s): A",
"B": "Arm Label: Cervarix Group; Type: EXPERIMENTAL; Interventions: Biological: Cervarix™ | Arm Label: Havrix Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: ... | C | [
"NCT00141193",
"NCT00122681",
"NCT00005094",
"NCT00081263"
] | 219 | train |
NCT00005578 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Advanced Stage Hodgkins Disease - A Pediatric Oncology Group Phase III Study
Brief Summary: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Chemoprot... | {
"A": "Arm Label: Cancer survivors; Type: N/A; Interventions: N/A | Arm Label: Sibling Controls; Type: N/A; Interventions: N/A",
"B": "Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Biological: bleomycin sulfate, Biological: filgrastim, Drug: cyclophosphamide, Drug: doxorubicin hydrochloride, Drug: etoposide... | B | [
"NCT01120353",
"NCT00005578",
"NCT00165087",
"NCT01790152"
] | 220 | train |
NCT00005669 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Metformin on Energy Intake, Energy Expenditure, and Body Weight in Overweight Children With Insulin Resistance
Brief Summary: This study will examine the safety and effectiveness of the medicine metformin to he... | {
"A": "Arm Label: Litramine; Type: EXPERIMENTAL; Interventions: Device: Litramine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Device: Placebo | Intervention Type: DEVICE; Name: Litramine; Assigned to Arm(s): Litramine | Intervention Type: DEVICE; Name: Placebo; Assigned to Arm(s): Placebo",
"B":... | C | [
"NCT01233349",
"NCT01425905",
"NCT00005669",
"NCT00120146"
] | 221 | train |
NCT00005775 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of Parenteral Glutamine Supplementation for Extremely-Low-Birth-Weight (ELBW) Infants
Brief Summary: This large multicenter double-masked clinical trial tested whether supplementation of standa... | {
"A": "Arm Label: Cycling Parenteral Nutrition; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Parenteral Nutrition | Arm Label: Continuous Parenteral Nutrition; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Parenteral Nutrition | Intervention Type: DIETARY_SUPPLEMENT; Name: Parenteral Nutritio... | D | [
"NCT01062815",
"NCT01813526",
"NCT01569776",
"NCT00005775"
] | 222 | train |
NCT00005889 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study of Gluconeogenesis in Very Low Birth Weight Infants Receiving Total Parenteral Nutrition
Brief Summary: RATIONALE: Very low birth weight infants have problems maintaining normal blood sugar levels. Gluconeogenesis i... | {
"A": "Arm Label: Amino acid based infant formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Amino acid based infant formula | Arm Label: Extensively hydrolyzed casein infant formula; Type: EXPERIMENTAL; Interventions: Other: Extensively hydrolyzed casein infant formula | Arm Label: Mother's own breast milk; Ty... | B | [
"NCT02500563",
"NCT00005889",
"NCT01109966",
"NCT01569776"
] | 223 | train |
NCT00005970 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase III Trial of Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Paclitaxel With or Without Trastuzumab as Adjuvant Treatment for Women With HER-2 Over-Expressing or Amplified Node Positive or High-Risk Node Ne... | {
"A": "Arm Label: Conventional radiotherapy; Type: ACTIVE_COMPARATOR; Interventions: Radiation: Conventional radiotherapy | Arm Label: Tomotherapy; Type: EXPERIMENTAL; Interventions: Radiation: Tomotherapy | Intervention Type: RADIATION; Name: Conventional radiotherapy; Assigned to Arm(s): Conventional radiotherapy ... | C | [
"NCT00459628",
"NCT00156052",
"NCT00005970",
"NCT00004067"
] | 224 | train |
NCT00005970 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase III Trial of Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Paclitaxel With or Without Trastuzumab as Adjuvant Treatment for Women With HER-2 Over-Expressing or Amplified Node Positive or High-Risk Node Ne... | {
"A": "Arm Label: Arm I (AC, paclitaxel, tamoxifen, aromatase inhibitor); Type: EXPERIMENTAL; Interventions: Drug: Aromatase Inhibition Therapy, Drug: Cyclophosphamide, Drug: Doxorubicin Hydrochloride, Other: Laboratory Biomarker Analysis, Drug: Paclitaxel, Drug: Tamoxifen Citrate | Arm Label: Arm II (AC, paclitaxel... | A | [
"NCT00005970",
"NCT00004067",
"NCT00288002",
"NCT00045032"
] | 225 | train |
NCT00006161 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Decompression Intervention of Variceal Rebleeding Trial
Brief Summary: The Decompression Intervention of Variceal Rebleeding Trial (DIVERT) is a multi-center prospective randomized clinical trial comparing the radiologic ... | {
"A": "Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: red blood cell transfusion | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: red blood cell transfusion | Intervention Type: PROCEDURE; Name: red blood cell transfusion; Assigned to Arm(s): 1, 2",
"B": "Intervention Type: PROC... | B | [
"NCT00414713",
"NCT00006161",
"NCT03388125",
"NCT02646202"
] | 226 | train |
NCT00006164 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Brief Summary: The HALT-C Trial is a National Institute of Diabetes and Digestive and Kidney Diseases sponsored, randomized clinical trial of long... | {
"A": "Arm Label: Peginterferon Alfa-2a + Ribavirin; Type: EXPERIMENTAL; Interventions: Drug: Ribavirin, Drug: Peginterferon alfa-2a [Pegasys] | Arm Label: Peginterferon Alfa-2b + Ribavirin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Peginterferon alfa-2b (PEG-Intron), Drug: Ribavirin | Intervention Type: DRUG; N... | C | [
"NCT00087607",
"NCT00081770",
"NCT00006164",
"NCT00502099"
] | 227 | train |
NCT00006164 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Brief Summary: The HALT-C Trial is a National Institute of Diabetes and Digestive and Kidney Diseases sponsored, randomized clinical trial of long... | {
"A": "Arm Label: PBO 12 Week+Peg-IFN-alfa-2a, RBV 48 Week; Type: PLACEBO_COMPARATOR; Interventions: Drug: Ribavirin, Drug: Pegylated Interferon Alfa 2a, Drug: Placebo | Arm Label: Telaprevir 12 Week +Peg-IFN-alfa-2a,RBV 24 Week; Type: EXPERIMENTAL; Interventions: Drug: Ribavirin, Drug: Pegylated Interferon Alfa 2a,... | B | [
"NCT00372385",
"NCT00006164",
"NCT00336479",
"NCT00483938"
] | 228 | train |
NCT00006164 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Brief Summary: The HALT-C Trial is a National Institute of Diabetes and Digestive and Kidney Diseases sponsored, randomized clinical trial of long... | {
"A": "Arm Label: Cohort A, Group 1 (12 wk): CPT Class B (7-9); Type: EXPERIMENTAL; Interventions: Drug: LDV/SOF, Drug: RBV | Arm Label: Cohort A, Group 1 (24 wk): CPT Class B (7-9); Type: EXPERIMENTAL; Interventions: Drug: LDV/SOF, Drug: RBV | Arm Label: Cohort A, Group 2 (12 wk): CPT Class C (10-12); Type: EXPERIM... | C | [
"NCT01938430",
"NCT01965535",
"NCT00006164",
"NCT03047603"
] | 229 | train |
NCT00006164 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Brief Summary: The HALT-C Trial is a National Institute of Diabetes and Digestive and Kidney Diseases sponsored, randomized clinical trial of long... | {
"A": "Arm Label: 1. Placebo + PEG + RBV; Type: PLACEBO_COMPARATOR; Interventions: Biological: Peginterferon alfa-2b (PEG), Drug: Ribavirin (RBV), Drug: Placebo | Arm Label: 2. Boceprevir + PEG + RBV - 24 Weeks (RGT); Type: EXPERIMENTAL; Interventions: Biological: Peginterferon alfa-2b (PEG), Drug: Ribavirin (RBV), ... | C | [
"NCT00705432",
"NCT00048724",
"NCT00006164",
"NCT00627926"
] | 230 | train |
NCT00006170 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bupropion and Weight Control for Smoking Cessation
Brief Summary: The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco ... | {
"A": "Arm Label: Standard support; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Reactive (standard) telephone support | Arm Label: Proactive telephone support; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Proactive telephone support | Arm Label: Standard support & offer NRT; Type: ACTIVE_COMPARATOR; I... | B | [
"NCT00775944",
"NCT00006170",
"NCT01451814",
"NCT01932996"
] | 231 | train |
NCT00006170 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bupropion and Weight Control for Smoking Cessation
Brief Summary: The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco ... | {
"A": "Arm Label: P; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bupropion HCl ER | Intervention Type: DRUG; Name: Bupropion HCl ER; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): P",
"B": "Arm Label: Bupr... | B | [
"NCT00689611",
"NCT00006170",
"NCT00701896",
"NCT01621009"
] | 232 | train |
NCT00006170 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bupropion and Weight Control for Smoking Cessation
Brief Summary: The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco ... | {
"A": "Arm Label: Varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline(Chantix) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline(Chantix); Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s)... | D | [
"NCT00523445",
"NCT01532232",
"NCT00463918",
"NCT00006170"
] | 233 | train |
NCT00006170 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bupropion and Weight Control for Smoking Cessation
Brief Summary: The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco ... | {
"A": "Arm Label: Bupropion and Weight Concerns intervention; Type: EXPERIMENTAL; Interventions: Drug: Bupropion, Behavioral: weight concerns intervention | Arm Label: Placebo and Weight Concerns; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo, Behavioral: weight concerns intervention | Arm Label: Bupropion a... | A | [
"NCT00006170",
"NCT01444131",
"NCT01509547",
"NCT00332644"
] | 234 | train |
NCT00006170 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bupropion and Weight Control for Smoking Cessation
Brief Summary: The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco ... | {
"A": "Arm Label: Bupropion; Type: EXPERIMENTAL; Interventions: Drug: Bupropion, Behavioral: Weekly Motivational Emails | Arm Label: Varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline, Behavioral: Weekly Motivational Emails | Intervention Type: DRUG; Name: Bupropion; Assigned to Arm(s): Bupropion | In... | C | [
"NCT02146911",
"NCT00296647",
"NCT00006170",
"NCT00176449"
] | 235 | train |
NCT00006170 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bupropion and Weight Control for Smoking Cessation
Brief Summary: The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco ... | {
"A": "Arm Label: Bupropion SR + Contingency Management; Type: EXPERIMENTAL; Interventions: Drug: Bupropion SR, Behavioral: Contingency Management | Arm Label: Placebo + Contingency Management; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Contingency Management, Other: Placebo | Arm Label: Bupropion SR + No C... | B | [
"NCT00330187",
"NCT00006170",
"NCT00087880",
"NCT00628225"
] | 236 | train |
NCT00006170 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bupropion and Weight Control for Smoking Cessation
Brief Summary: The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco ... | {
"A": "Arm Label: PROOF cohort; Type: N/A; Interventions: N/A",
"B": "Intervention Type: DRUG; Name: varenicline (CP-526,555); Assigned to Arm(s): N/A",
"C": "Arm Label: Bupropion and Weight Concerns intervention; Type: EXPERIMENTAL; Interventions: Drug: Bupropion, Behavioral: weight concerns intervention | Arm ... | C | [
"NCT00759304",
"NCT00141206",
"NCT00006170",
"NCT00224419"
] | 237 | train |
NCT00006170 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bupropion and Weight Control for Smoking Cessation
Brief Summary: The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco ... | {
"A": "Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: varenicline; Type: EXPERIMENTAL; Interventions: Drug: varenicline | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo | Intervention Type: DRUG; Name: varenicline; Assigned to Arm(s): varenicline",
"B":... | D | [
"NCT00691483",
"NCT00150228",
"NCT00143325",
"NCT00006170"
] | 238 | train |
NCT00006170 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bupropion and Weight Control for Smoking Cessation
Brief Summary: The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco ... | {
"A": "Arm Label: Comprehensive intervention; Type: EXPERIMENTAL; Interventions: Other: Comprehensive smoking cessation intervention | Arm Label: Enhanced usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced usual care | Intervention Type: OTHER; Name: Comprehensive smoking cessation intervention... | B | [
"NCT02188563",
"NCT00006170",
"NCT00666978",
"NCT00087880"
] | 239 | train |
NCT00006170 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bupropion and Weight Control for Smoking Cessation
Brief Summary: The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco ... | {
"A": "Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Champix | Intervention Type: DRUG; Name: Champix; Assigned to Arm(s): Placebo",
"B": "Arm Label: Bupropion and Weight Concerns intervention; Type: EXPERIMENTAL; Interventions: Drug: Bupropion, Behavioral: weight concerns intervention | Arm L... | B | [
"NCT01243203",
"NCT00006170",
"NCT00794573",
"NCT02271919"
] | 240 | train |
NCT00006170 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bupropion and Weight Control for Smoking Cessation
Brief Summary: The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco ... | {
"A": "Arm Label: Bupropion and Weight Concerns intervention; Type: EXPERIMENTAL; Interventions: Drug: Bupropion, Behavioral: weight concerns intervention | Arm Label: Placebo and Weight Concerns; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo, Behavioral: weight concerns intervention | Arm Label: Bupropion a... | A | [
"NCT00006170",
"NCT00775944",
"NCT00297466",
"NCT00440115"
] | 241 | train |
NCT00006170 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bupropion and Weight Control for Smoking Cessation
Brief Summary: The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco ... | {
"A": "Arm Label: Bupropion and Weight Concerns intervention; Type: EXPERIMENTAL; Interventions: Drug: Bupropion, Behavioral: weight concerns intervention | Arm Label: Placebo and Weight Concerns; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo, Behavioral: weight concerns intervention | Arm Label: Bupropion a... | A | [
"NCT00006170",
"NCT00794573",
"NCT00141206",
"NCT00894166"
] | 242 | train |
NCT00006177 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Phenomenology and Neurophysiology of Affective Dysregulation in Children and Adolescents With Bipolar Disorder
Brief Summary: This research protocol seeks to learn more about bipolar disorder in children and adolescen... | {
"A": "Arm Label: Stepping Stones Triple P; Type: EXPERIMENTAL; Interventions: Behavioral: Level 4 Stepping Stones Triple P (SSTP) | Arm Label: Treatment as usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Level 4 Stepping Stones Triple P (SSTP); Assigned to Arm(s): Stepp... | C | [
"NCT03086876",
"NCT01680276",
"NCT00006177",
"NCT02797418"
] | 243 | train |
NCT00006182 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To determine how long blood transfusions are needed for primary stroke prevention. Also, to determine the duration of risk associated with abnormal transcranial Doppler ultrasound (TCD) and to determine... | {
"A": "Intervention Type: PROCEDURE; Name: blood transfusion; Assigned to Arm(s): N/A",
"B": "Arm Label: Standard Therapy; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Treatment Arm; Type: EXPERIMENTAL; Interventions: Drug: Hydroxyurea | Intervention Type: DRUG; Name: Hydroxyurea; Assigned to Arm(s): Tre... | C | [
"NCT00000592",
"NCT01425307",
"NCT00006182",
"NCT00122980"
] | 244 | train |
NCT00006182 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To determine how long blood transfusions are needed for primary stroke prevention. Also, to determine the duration of risk associated with abnormal transcranial Doppler ultrasound (TCD) and to determine... | {
"A": "Arm Label: Blood Transfusion Trial Cohort; Type: ACTIVE_COMPARATOR; Interventions: Biological: Single blood transfusion | Arm Label: Standard Care Trial Cohort; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard care | Arm Label: Standard Care Observational Cohort; Type: ACTIVE_COMPARATOR; Intervent... | D | [
"NCT00951808",
"NCT01794000",
"NCT00072761",
"NCT00006182"
] | 245 | train |
NCT00006182 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To determine how long blood transfusions are needed for primary stroke prevention. Also, to determine the duration of risk associated with abnormal transcranial Doppler ultrasound (TCD) and to determine... | {
"A": "Arm Label: Standard Therapy; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Treatment Arm; Type: EXPERIMENTAL; Interventions: Drug: Hydroxyurea | Intervention Type: DRUG; Name: Hydroxyurea; Assigned to Arm(s): Treatment Arm",
"B": "Intervention Type: PROCEDURE; Name: Blood Transfusion; Assigned to A... | B | [
"NCT01425307",
"NCT00006182",
"NCT00072761",
"NCT00122980"
] | 246 | train |
NCT00006182 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To determine how long blood transfusions are needed for primary stroke prevention. Also, to determine the duration of risk associated with abnormal transcranial Doppler ultrasound (TCD) and to determine... | {
"A": "Arm Label: Transfusion Group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: transfusion therapy | Arm Label: Observation Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: transfusion therapy; Assigned to Arm(s): Transfusion Group",
"B": "Intervention Type: PROCEDURE... | C | [
"NCT00072761",
"NCT00000592",
"NCT00006182",
"NCT01531387"
] | 247 | train |
NCT00006182 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To determine how long blood transfusions are needed for primary stroke prevention. Also, to determine the duration of risk associated with abnormal transcranial Doppler ultrasound (TCD) and to determine... | {
"A": "Arm Label: Hydroxyurea; Type: ACTIVE_COMPARATOR; Interventions: Drug: Hydroxyurea | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Hydroxyurea; Assigned to Arm(s): Hydroxyurea | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo",
... | C | [
"NCT00006400",
"NCT00072761",
"NCT00006182",
"NCT01425307"
] | 248 | train |
NCT00006182 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To determine how long blood transfusions are needed for primary stroke prevention. Also, to determine the duration of risk associated with abnormal transcranial Doppler ultrasound (TCD) and to determine... | {
"A": "Intervention Type: PROCEDURE; Name: Blood Transfusion; Assigned to Arm(s): N/A",
"B": "Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Hydroxyurea, Procedure: Phlebotomy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Red Cell Transfusions, Procedure: Iron Chelation | Interven... | A | [
"NCT00006182",
"NCT00122980",
"NCT00951808",
"NCT01425307"
] | 249 | train |
NCT00006182 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To determine how long blood transfusions are needed for primary stroke prevention. Also, to determine the duration of risk associated with abnormal transcranial Doppler ultrasound (TCD) and to determine... | {
"A": "Intervention Type: PROCEDURE; Name: blood transfusion; Assigned to Arm(s): N/A",
"B": "Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Hydroxyurea, Procedure: Phlebotomy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Red Cell Transfusions, Procedure: Iron Chelation | Interven... | C | [
"NCT00000592",
"NCT00122980",
"NCT00006182",
"NCT01425307"
] | 250 | train |
NCT00006183 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hematocrit Strategy in Infant Heart Surgery
Brief Summary: The purpose of this study is to compare the effects of diluted hematocrit (HCT) levels of 35% versus 25% during hypothermic cardiopulmonary bypass (CPB) in infant... | {
"A": "Arm Label: Shorter-storage red blood cell units; Type: ACTIVE_COMPARATOR; Interventions: Biological: Red blood cell units stored <= 10 days | Arm Label: Longer-storage red blood cell units; Type: ACTIVE_COMPARATOR; Interventions: Biological: Red blood cell units stored >= 21 days | Intervention Type: BIOLOGIC... | D | [
"NCT00991341",
"NCT00326924",
"NCT00693498",
"NCT00006183"
] | 251 | train |
NCT00006206 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: COMBINE: Effect of Combined Pharmacotherapies and Behavioral Interventions
Brief Summary: Combine is a multicenter, randomized clinical trial that will evaluate combinations of three interventions for treating alcohol dep... | {
"A": "Intervention Type: DRUG; Name: naltrexone (Revia); Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: acamprosate (Campral); Assigned to Arm(s): N/A",
"B": "Intervention Type: DRUG; Name: methylphenidate hydrochloride extended-release tablets; Assigned to Arm(s): N/A",
"C": "N/A",
"D": "Arm Label:... | A | [
"NCT00006206",
"NCT00326300",
"NCT00550667",
"NCT02675400"
] | 252 | train |
NCT00006206 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: COMBINE: Effect of Combined Pharmacotherapies and Behavioral Interventions
Brief Summary: Combine is a multicenter, randomized clinical trial that will evaluate combinations of three interventions for treating alcohol dep... | {
"A": "Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Naltrexone | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Naltrexone plus Gabapentin | Arm Label: 3; Type: SHAM_COMPARATOR; Interventions: Other: Inactive Placebo | Intervention Type: DRUG; Name: Naltrexone; Assigned to Arm(s): 1 | Int... | D | [
"NCT00183196",
"NCT00758277",
"NCT00210925",
"NCT00006206"
] | 253 | train |
NCT00006249 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: PEG-Intron Observation After Regional Lymph Node Dissection in AJCC Stage III (TxN1-2MO) Melanoma Patients: a Randomized Phase III Trial
Brief Summary: RATIONALE: Interferon alfa may interfere with the growth of the cance... | {
"A": "Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Biological: MDX-1379 (gp100) Melanoma Peptide Vaccine | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: MDX-010 (anti-CTLA4) monoclonal antibody, Biological: MDX-1379 (gp100) Melanoma Peptide Vaccine | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interven... | B | [
"NCT00094653",
"NCT00006249",
"NCT00275496",
"NCT01006980"
] | 254 | train |
NCT00006286 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment for Adolescents With Depression Study (TADS)
Brief Summary: TADS is designed to compare the effectiveness of established treatments for teenagers suffering from major depressive disorder (MDD). The treatments ar... | {
"A": "Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aripiprazole | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aripiprazole | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Aripiprazole; Assigned to Arm(s): 1 | Intervention Type: D... | B | [
"NCT00110461",
"NCT00006286",
"NCT00018902",
"NCT00604097"
] | 255 | train |
NCT00006286 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment for Adolescents With Depression Study (TADS)
Brief Summary: TADS is designed to compare the effectiveness of established treatments for teenagers suffering from major depressive disorder (MDD). The treatments ar... | {
"A": "Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Psychotherapy; Assigned to Arm(s): N/A",
"B": "Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Fluoxetine, Drug: Citalopram | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Venlafaxine | ... | A | [
"NCT00006286",
"NCT00018902",
"NCT00080158",
"NCT00508859"
] | 256 | train |
NCT00006286 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment for Adolescents With Depression Study (TADS)
Brief Summary: TADS is designed to compare the effectiveness of established treatments for teenagers suffering from major depressive disorder (MDD). The treatments ar... | {
"A": "Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Psychotherapy; Assigned to Arm(s): N/A",
"B": "Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive behavioral therapy (CBT), Drug: Drug therapy | Arm Label: 2; Type: ACTIVE_COMPARATOR... | A | [
"NCT00006286",
"NCT00158301",
"NCT00107120",
"NCT00508859"
] | 257 | train |
NCT00006294 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pharmacological Association of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on Blood Pressure and Cardiovascular Risk in Relation to Anti-hypertensive Treatment
Brief Summary: To examine whether the a... | {
"A": "Arm Label: Chlorthalidone; Type: N/A; Interventions: Drug: Chlorthalidone | Arm Label: Amlodipine; Type: N/A; Interventions: Drug: Amlodipine | Arm Label: Lisinopril; Type: N/A; Interventions: Drug: Lisinopril | Arm Label: Doxazosin; Type: N/A; Interventions: Drug: Doxazosin | Intervention Type: DRUG; Name: C... | A | [
"NCT00006294",
"NCT00605072",
"NCT00000542",
"NCT00338260"
] | 258 | train |
NCT00006305 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes
Brief Summary: The BARI 2D trial is a multicenter study that uses a 2x2 factorial design, with 2400 patients being assigned at random to initial electi... | {
"A": "Arm Label: desvenlafaxine succinate sustained-release (DVS SR) 50mg; Type: EXPERIMENTAL; Interventions: Drug: DVS SR | Arm Label: desvenlafaxine succinate sustained-release (DVS SR) 100mg; Type: EXPERIMENTAL; Interventions: Drug: DVS SR | Arm Label: desvenlafaxine succinate sustained-release (DVS SR) 200mg; T... | C | [
"NCT00283842",
"NCT01050218",
"NCT00006305",
"NCT00032487"
] | 259 | train |
NCT00006305 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes
Brief Summary: The BARI 2D trial is a multicenter study that uses a 2x2 factorial design, with 2400 patients being assigned at random to initial electi... | {
"A": "Arm Label: Lira 1.8; Type: EXPERIMENTAL; Interventions: Drug: liraglutide, Drug: placebo | Arm Label: Lira 1.2; Type: EXPERIMENTAL; Interventions: Drug: liraglutide, Drug: placebo | Arm Label: Glimepiride - 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: glimepiride, Drug: placebo | Arm Label: Glimepiride - ... | D | [
"NCT00294723",
"NCT00032487",
"NCT01472432",
"NCT00006305"
] | 260 | train |
NCT00006305 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes
Brief Summary: The BARI 2D trial is a multicenter study that uses a 2x2 factorial design, with 2400 patients being assigned at random to initial electi... | {
"A": "Arm Label: Saxagliptin 2.5 mg + Glyburide 7.5 mg (A); Type: EXPERIMENTAL; Interventions: Drug: Saxagliptin, Drug: Glyburide, Drug: Metformin | Arm Label: Saxagliptin 5 mg + Glyburide 7.5 mg (B); Type: EXPERIMENTAL; Interventions: Drug: Saxagliptin, Drug: Glyburide, Drug: Metformin | Arm Label: Placebo + Glybu... | C | [
"NCT00313313",
"NCT00320008",
"NCT00006305",
"NCT01792518"
] | 261 | train |
NCT00006327 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Trial to Determine the Efficacy of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand
Brief Summary: The purpose of this study is to determine if the vaccine, AIDSVAX B/E, will protect intraven... | {
"A": "Intervention Type: BIOLOGICAL; Name: MN rgp120/HIV-1 and A244 rgp120/HIV-1; Assigned to Arm(s): N/A",
"B": "Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Screening for intimate partner violence | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Screening fo... | A | [
"NCT00006327",
"NCT00182468",
"NCT02258425",
"NCT01180647"
] | 262 | train |
NCT00006327 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Trial to Determine the Efficacy of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand
Brief Summary: The purpose of this study is to determine if the vaccine, AIDSVAX B/E, will protect intraven... | {
"A": "Intervention Type: BIOLOGICAL; Name: MN rgp120/HIV-1 and A244 rgp120/HIV-1; Assigned to Arm(s): N/A",
"B": "Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Methadone | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s):... | A | [
"NCT00006327",
"NCT00657397",
"NCT01844414",
"NCT01270100"
] | 263 | train |
NCT00006353 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Concomitant and Adjuvant Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme - A Randomized Phase III Study
Brief Summary: RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. ... | {
"A": "Arm Label: Radiotherapy; Type: ACTIVE_COMPARATOR; Interventions: Radiation: Radiation therapy | Arm Label: Radiotherapy plus Bevacizumab; Type: EXPERIMENTAL; Interventions: Drug: Bevacizumab | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): Radiotherapy plus Bevacizumab | Intervention Type: RA... | C | [
"NCT01443676",
"NCT01022918",
"NCT00006353",
"NCT00884741"
] | 264 | train |
NCT00006353 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Concomitant and Adjuvant Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme - A Randomized Phase III Study
Brief Summary: RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. ... | {
"A": "Arm Label: Vaccination; Type: EXPERIMENTAL; Interventions: Biological: autologous dendritic cells | Intervention Type: BIOLOGICAL; Name: autologous dendritic cells; Assigned to Arm(s): Vaccination",
"B": "Intervention Type: DRUG; Name: temozolomide; Assigned to Arm(s): N/A | Intervention Type: RADIATION; Na... | B | [
"NCT01006044",
"NCT00006353",
"NCT01502241",
"NCT01480479"
] | 265 | train |
NCT00006353 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Concomitant and Adjuvant Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme - A Randomized Phase III Study
Brief Summary: RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. ... | {
"A": "Intervention Type: DRUG; Name: temozolomide; Assigned to Arm(s): N/A | Intervention Type: RADIATION; Name: radiation therapy; Assigned to Arm(s): N/A",
"B": "Arm Label: Cediranib & Gefitinib; Type: ACTIVE_COMPARATOR; Interventions: Drug: cediranib maleate, Drug: gefitinib | Arm Label: Cediranbib & placebo; ... | A | [
"NCT00006353",
"NCT01310855",
"NCT00482677",
"NCT00017147"
] | 266 | train |
NCT00006353 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Concomitant and Adjuvant Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme - A Randomized Phase III Study
Brief Summary: RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. ... | {
"A": "Intervention Type: DRUG; Name: temozolomide; Assigned to Arm(s): N/A | Intervention Type: RADIATION; Name: radiation therapy; Assigned to Arm(s): N/A",
"B": "Arm Label: Specialised palliative care (SPC) group; Type: EXPERIMENTAL; Interventions: Other: Specialised palliative care (SPC) | Arm Label: Standard ... | A | [
"NCT00006353",
"NCT01348048",
"NCT01245621",
"NCT01248624"
] | 267 | train |
NCT00006353 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Concomitant and Adjuvant Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme - A Randomized Phase III Study
Brief Summary: RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. ... | {
"A": "Intervention Type: DRUG; Name: temozolomide; Assigned to Arm(s): N/A | Intervention Type: RADIATION; Name: radiation therapy; Assigned to Arm(s): N/A",
"B": "Arm Label: Radiotherapy; Type: ACTIVE_COMPARATOR; Interventions: Radiation: Radiotherapy of the partial brain. | Arm Label: Temozolomide; Type: EXPERI... | A | [
"NCT00006353",
"NCT01502241",
"NCT00002840",
"NCT00482677"
] | 268 | train |
NCT00006392 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Brief Summary: RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. It is not yet known wh... | {
"A": "Intervention Type: BEHAVIORAL; Name: dietary supplements; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: vitamin C; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: vitamin E; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: beta-carotene; Assigned to Arm(s): N/A | Intervention Type:... | C | [
"NCT00000541",
"NCT00671346",
"NCT00006392",
"NCT00270647"
] | 269 | train |
NCT00006392 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Brief Summary: RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. It is not yet known wh... | {
"A": "Arm Label: Vitamin E + selenium placebo; Type: EXPERIMENTAL; Interventions: Drug: Vitamin E, Other: selenium placebo | Arm Label: Selenium + vitamin E placebo; Type: EXPERIMENTAL; Interventions: Drug: Selenium, Other: Vitamin E placebo | Arm Label: Vitamin E + selenium; Type: EXPERIMENTAL; Interventions: Drug... | A | [
"NCT00006392",
"NCT01320527",
"NCT00982202",
"NCT00270647"
] | 270 | train |
NCT00006392 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Brief Summary: RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. It is not yet known wh... | {
"A": "Arm Label: Vitamin E + selenium placebo; Type: EXPERIMENTAL; Interventions: Drug: Vitamin E, Other: selenium placebo | Arm Label: Selenium + vitamin E placebo; Type: EXPERIMENTAL; Interventions: Drug: Selenium, Other: Vitamin E placebo | Arm Label: Vitamin E + selenium; Type: EXPERIMENTAL; Interventions: Drug... | A | [
"NCT00006392",
"NCT00431691",
"NCT00220831",
"NCT00000479"
] | 271 | train |
NCT00006392 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Brief Summary: RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. It is not yet known wh... | {
"A": "Arm Label: Vitamin E; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin E | Arm Label: Vitamin C; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin C | Arm Label: Multivitamin; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Multivitamin | Arm Label: Beta-carotene; Type: EXPER... | D | [
"NCT00270647",
"NCT00002540",
"NCT00000611",
"NCT00006392"
] | 272 | train |
NCT00006392 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Brief Summary: RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. It is not yet known wh... | {
"A": "Arm Label: telephone; Type: EXPERIMENTAL; Interventions: Behavioral: telephone | Arm Label: face-to-face; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: consultation face-to-face | Intervention Type: BEHAVIORAL; Name: telephone; Assigned to Arm(s): telephone | Intervention Type: BEHAVIORAL; Name: consult... | D | [
"NCT02570061",
"NCT00000611",
"NCT01502254",
"NCT00006392"
] | 273 | train |
NCT00006392 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Brief Summary: RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. It is not yet known wh... | {
"A": "Arm Label: Vitamin E + selenium placebo; Type: EXPERIMENTAL; Interventions: Drug: Vitamin E, Other: selenium placebo | Arm Label: Selenium + vitamin E placebo; Type: EXPERIMENTAL; Interventions: Drug: Selenium, Other: Vitamin E placebo | Arm Label: Vitamin E + selenium; Type: EXPERIMENTAL; Interventions: Drug... | A | [
"NCT00006392",
"NCT00272428",
"NCT00270647",
"NCT01320527"
] | 274 | train |
NCT00006392 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Brief Summary: RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. It is not yet known wh... | {
"A": "Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Study Arm A | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Study Arm B | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Study Arm C | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interv... | D | [
"NCT00362518",
"NCT00272428",
"NCT00982202",
"NCT00006392"
] | 275 | train |
NCT00006392 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Brief Summary: RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. It is not yet known wh... | {
"A": "Arm Label: Saffron; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Saffron | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Saffron; Assigned to Arm(s): Saffron | Intervention Type: DIETARY_SUPPLEMENT; Name: ... | B | [
"NCT00951288",
"NCT00006392",
"NCT00270647",
"NCT00000152"
] | 276 | train |
NCT00006392 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Brief Summary: RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. It is not yet known wh... | {
"A": "Arm Label: Vitamin E + selenium placebo; Type: EXPERIMENTAL; Interventions: Drug: Vitamin E, Other: selenium placebo | Arm Label: Selenium + vitamin E placebo; Type: EXPERIMENTAL; Interventions: Drug: Selenium, Other: Vitamin E placebo | Arm Label: Vitamin E + selenium; Type: EXPERIMENTAL; Interventions: Drug... | A | [
"NCT00006392",
"NCT00279812",
"NCT00428649",
"NCT00272428"
] | 277 | train |
NCT00006398 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized, Double-Blind Study of Timolol (A Nonselective Beta-Adrenergic Blocker) vs Placebo to Prevent Complications of Hepatic Portal Hypertension in Patients With Cirrhosis
Brief Summary: The purpose of this study is ... | {
"A": "Arm Label: Endoscopic Variceal Ligation; Type: ACTIVE_COMPARATOR; Interventions: Device: multi band ligator for esophageal varices | Arm Label: Propranolol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Propranolol | Intervention Type: DRUG; Name: Propranolol; Assigned to Arm(s): Propranolol | Intervention Ty... | C | [
"NCT01000779",
"NCT00690027",
"NCT00006398",
"NCT00734227"
] | 278 | train |
NCT00006400 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG)
Brief Summary: The purpose of this study is to determine if hydroxyurea therapy is effective in the prevention of chronic end organ damage in pediatric patients wi... | {
"A": "Arm Label: Hydroxyurea; Type: ACTIVE_COMPARATOR; Interventions: Drug: Hydroxyurea | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Hydroxyurea; Assigned to Arm(s): Hydroxyurea | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo",
... | A | [
"NCT00006400",
"NCT00305175",
"NCT01891292",
"NCT01096121"
] | 279 | train |
NCT00006400 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG)
Brief Summary: The purpose of this study is to determine if hydroxyurea therapy is effective in the prevention of chronic end organ damage in pediatric patients wi... | {
"A": "Arm Label: Hydroxyurea; Type: ACTIVE_COMPARATOR; Interventions: Drug: Hydroxyurea | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Hydroxyurea; Assigned to Arm(s): Hydroxyurea | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo",
... | A | [
"NCT00006400",
"NCT01771731",
"NCT02467257",
"NCT01715480"
] | 280 | train |
NCT00006400 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG)
Brief Summary: The purpose of this study is to determine if hydroxyurea therapy is effective in the prevention of chronic end organ damage in pediatric patients wi... | {
"A": "Arm Label: Standard Therapy; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Treatment Arm; Type: EXPERIMENTAL; Interventions: Drug: Hydroxyurea | Intervention Type: DRUG; Name: Hydroxyurea; Assigned to Arm(s): Treatment Arm",
"B": "Arm Label: Hydroxyurea; Type: ACTIVE_COMPARATOR; Interventions: Drug... | B | [
"NCT01425307",
"NCT00006400",
"NCT00122980",
"NCT00072761"
] | 281 | train |
NCT00006400 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG)
Brief Summary: The purpose of this study is to determine if hydroxyurea therapy is effective in the prevention of chronic end organ damage in pediatric patients wi... | {
"A": "Intervention Type: PROCEDURE; Name: Blood Transfusion; Assigned to Arm(s): N/A",
"B": "Arm Label: Transfusion Group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: transfusion therapy | Arm Label: Observation Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: transfus... | C | [
"NCT00006182",
"NCT00072761",
"NCT00006400",
"NCT01340404"
] | 282 | train |
NCT00006400 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG)
Brief Summary: The purpose of this study is to determine if hydroxyurea therapy is effective in the prevention of chronic end organ damage in pediatric patients wi... | {
"A": "Arm Label: Blood Transfusion Trial Cohort; Type: ACTIVE_COMPARATOR; Interventions: Biological: Single blood transfusion | Arm Label: Standard Care Trial Cohort; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard care | Arm Label: Standard Care Observational Cohort; Type: ACTIVE_COMPARATOR; Intervent... | D | [
"NCT00951808",
"NCT00006182",
"NCT00122980",
"NCT00006400"
] | 283 | train |
NCT00006400 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG)
Brief Summary: The purpose of this study is to determine if hydroxyurea therapy is effective in the prevention of chronic end organ damage in pediatric patients wi... | {
"A": "Arm Label: Placebo Pills and Placebo Liquid; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo Pills and Placebo Liquid | Arm Label: Hydroxyurea Pills and Placebo Liquid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Hydroxyurea | Arm Label: Placebo Pills and Magnesium Pidolate Liquid; Type: ACTIVE_COMP... | D | [
"NCT00532883",
"NCT01976416",
"NCT01425307",
"NCT00006400"
] | 284 | train |
NCT00006400 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG)
Brief Summary: The purpose of this study is to determine if hydroxyurea therapy is effective in the prevention of chronic end organ damage in pediatric patients wi... | {
"A": "Arm Label: Hydroxyurea; Type: ACTIVE_COMPARATOR; Interventions: Drug: Hydroxyurea | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Hydroxyurea; Assigned to Arm(s): Hydroxyurea | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo",
... | A | [
"NCT00006400",
"NCT01976416",
"NCT02560935",
"NCT03789591"
] | 285 | train |
NCT00006401 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Inhaled NO for the Prevention of Chronic Lung Disease
Brief Summary: To determine whether or not inhaled nitric oxide (iNO) safely decreases the incidence of chronic lung disease (CLD) in premature infants.
| {
"A": "Intervention Type: PROCEDURE; Name: mechanical ventilation; Assigned to Arm(s): N/A",
"B": "Arm Label: Inhaled Nitric Oxide (iNO); Type: EXPERIMENTAL; Interventions: Drug: iNO | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: iNO; Assigned to Arm(... | B | [
"NCT00000548",
"NCT00006401",
"NCT00955487",
"NCT00551642"
] | 286 | train |
NCT00006409 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trial of Activity for Adolescent Girls (TAAG)
Brief Summary: To test the effectiveness of a multicomponent school-based and community-linked intervention in preventing the decline in physical activity levels and cardiovas... | {
"A": "Arm Label: SCORES; Type: EXPERIMENTAL; Interventions: Behavioral: America SCORES, Bay Area | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: America SCORES, Bay Area; Assigned to Arm(s): SCORES",
"B": "Arm Label: School based intervention; Type: EXPERI... | C | [
"NCT01156103",
"NCT00458029",
"NCT00006409",
"NCT00176371"
] | 287 | train |
NCT00006409 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trial of Activity for Adolescent Girls (TAAG)
Brief Summary: To test the effectiveness of a multicomponent school-based and community-linked intervention in preventing the decline in physical activity levels and cardiovas... | {
"A": "Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity guidance, Behavioral: Health education | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Physical activity guidance; Assigned to Arm(s): Intervention | Intervention Ty... | D | [
"NCT02074332",
"NCT03504059",
"NCT00458029",
"NCT00006409"
] | 288 | train |
NCT00006409 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trial of Activity for Adolescent Girls (TAAG)
Brief Summary: To test the effectiveness of a multicomponent school-based and community-linked intervention in preventing the decline in physical activity levels and cardiovas... | {
"A": "Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: Primary (Environmental) Weight Gain Prevention | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Behavioral: Primary (Environmental) Weight Gain Prevention, Behavioral: Secondary (Behavioral) Weight Gain Prevention | Arm Label: Arm 3; Type:... | C | [
"NCT00289315",
"NCT00248469",
"NCT00006409",
"NCT00988754"
] | 289 | train |
NCT00006409 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trial of Activity for Adolescent Girls (TAAG)
Brief Summary: To test the effectiveness of a multicomponent school-based and community-linked intervention in preventing the decline in physical activity levels and cardiovas... | {
"A": "Arm Label: School-based intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Trial of Activity for Adolescent Girls (TAAG) | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Trial of Activity for Adolescent Girls (TAAG); Assigned to Arm(s): Sch... | A | [
"NCT00006409",
"NCT00454610",
"NCT00107692",
"NCT00067925"
] | 290 | train |
NCT00006409 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trial of Activity for Adolescent Girls (TAAG)
Brief Summary: To test the effectiveness of a multicomponent school-based and community-linked intervention in preventing the decline in physical activity levels and cardiovas... | {
"A": "Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: Primary (Environmental) Weight Gain Prevention | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Behavioral: Primary (Environmental) Weight Gain Prevention, Behavioral: Secondary (Behavioral) Weight Gain Prevention | Arm Label: Arm 3; Type:... | C | [
"NCT00289315",
"NCT01602796",
"NCT00006409",
"NCT02228434"
] | 291 | train |
NCT00006479 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pre- and Post-Operative Chemotherapy With Oxaliplatin 5FU/LV Versus Surgery Alone in Resectable Liver Metastases From Colorectal Origin - Phase III Study
Brief Summary: RATIONALE: Drugs used in chemotherapy use different ... | {
"A": "Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Intermittent Pringle maneuver | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Intermittent Pringle maneuver; Assigned to Arm(s): 1",
"B": "Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: N... | C | [
"NCT00730743",
"NCT00200148",
"NCT00006479",
"NCT01099475"
] | 292 | train |
NCT00006489 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Naltrexone and Cognitive-Behavioral Therapy for Patients With Alcoholism and Post-Traumatic Stress Disorder
Brief Summary: This study will evaluate naltrexone and cognitive-behavioral therapy treatments for alcohol depend... | {
"A": "Arm Label: Seeking Safety; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Modified Seeking Safety integrated into std outpatient SUD care | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard outpatient SUD care | Intervention Type: BEHAVIORAL; Name: Modified Seeking Safet... | B | [
"NCT00265564",
"NCT00006489",
"NCT01457391",
"NCT00278447"
] | 293 | train |
NCT00006734 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trial of Chemotherapy Intensification Through Compression in Ewing's Sarcoma and Related Tumors
Brief Summary: RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop gr... | {
"A": "Arm Label: Regimen A; Type: EXPERIMENTAL; Interventions: Biological: filgrastim, Drug: cyclophosphamide, Drug: doxorubicin hydrochloride, Drug: etoposide, Drug: ifosfamide, Drug: vincristine sulfate, Procedure: adjuvant therapy, Procedure: conventional surgery, Procedure: neoadjuvant therapy, Radiation: brach... | A | [
"NCT00006734",
"NCT00061984",
"NCT01655888",
"NCT01804374"
] | 294 | train |
NCT00007189 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
Brief Summary: The purpose of this trial is to test the ability of the non-steroidal anti-inflammatory medications naproxen and celecoxib to delay or prevent ... | {
"A": "Arm Label: Evidence-based treatment, lifestyle counseling; Type: EXPERIMENTAL; Interventions: Other: Systematic detection of vascular risk factors and subsequent evidence-based treatment | Intervention Type: OTHER; Name: Systematic detection of vascular risk factors and subsequent evidence-based treatment; As... | D | [
"NCT01107548",
"NCT01206062",
"NCT00000611",
"NCT00007189"
] | 295 | train |
NCT00007189 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
Brief Summary: The purpose of this trial is to test the ability of the non-steroidal anti-inflammatory medications naproxen and celecoxib to delay or prevent ... | {
"A": "Intervention Type: DRUG; Name: Naproxen Sodium (Aleve); Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Celecoxib (Celebrex); Assigned to Arm(s): N/A",
"B": "Intervention Type: PROCEDURE; Name: quality-of-life assessment; Assigned to Arm(s): N/A",
"C": "Intervention Type: DRUG; Name: Celecoxib (C... | A | [
"NCT00007189",
"NCT00090974",
"NCT00050479",
"NCT00078897"
] | 296 | train |
NCT00007501 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: CSP #403 - Trial of Varicella Zoster Vaccine for the Prevention of Herpes Zoster and Its Complications
Brief Summary: The incidence and severity of HZ (or shingles), as well as the frequency and severity of its complicati... | {
"A": "Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Biological: Varicella-zoster vaccine | Arm Label: Arm 2; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Varicella-zoster vaccine; Assigned to Arm(s): Arm 1 | Intervention Type: BIOLOGICAL; Name: Placebo; ... | A | [
"NCT00007501",
"NCT02114333",
"NCT01165229",
"NCT02075515"
] | 297 | train |
NCT00007501 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: CSP #403 - Trial of Varicella Zoster Vaccine for the Prevention of Herpes Zoster and Its Complications
Brief Summary: The incidence and severity of HZ (or shingles), as well as the frequency and severity of its complicati... | {
"A": "Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Biological: Varicella-zoster vaccine | Arm Label: Arm 2; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Varicella-zoster vaccine; Assigned to Arm(s): Arm 1 | Intervention Type: BIOLOGICAL; Name: Placebo; ... | A | [
"NCT00007501",
"NCT00444457",
"NCT00432523",
"NCT00127023"
] | 298 | train |
NCT00007501 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: CSP #403 - Trial of Varicella Zoster Vaccine for the Prevention of Herpes Zoster and Its Complications
Brief Summary: The incidence and severity of HZ (or shingles), as well as the frequency and severity of its complicati... | {
"A": "Arm Label: A - Live zoster vaccine; Type: ACTIVE_COMPARATOR; Interventions: Biological: Zostavax, Biological: Placebo | Arm Label: B - recombinant zoster vaccine; Type: ACTIVE_COMPARATOR; Interventions: Biological: HZ/su vaccine | Arm Label: C - Live zoster vaccine; Type: ACTIVE_COMPARATOR; Interventions: Bio... | B | [
"NCT02114333",
"NCT00007501",
"NCT01777321",
"NCT01385566"
] | 299 | train |